Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry

The purpose of this registry is to obtain case reports of physician experience with the Spiral-Z® graft under routine clinical care.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Abdominal Aortic Aneurysm Aneurysm Aortic Aneurysm Aortic Aneurysm, Abdominal Aortic Diseases Aorto-iliac Aneurysm Cardiovascular Diseases Vascular Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Hamilton General Hospital, Hamilton, Ontario, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient is implanted with Zenith® Spiral-Z® AAA Iliac Leg Graft.

Exclusion criteria

Patients for whom this device would not normally be considered standard of care.

Treatment and study plan

Iliac Leg Graft

Device

Zenith® Spiral-Z® AAA Iliac Leg Graft

Primary outcomes

Assess short term and longer term outcomes, including outcomes related to patency, of the Zenith® Spiral-Z® AAA Iliac Leg Graft.

Time frame: 12 months

Sponsors and collaborators

Lead sponsor

Cook Group Incorporated

Industry

Registry information

Important dates

Study start: 2012
Primary completion: 2016
Study completion: 2016
First posted: Feb 29, 2012
Registry last updated: Jan 20, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed